These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 39014082)
21. PLK2 modulation of enriched TAp73 affects osteogenic differentiation and prognosis in human osteosarcoma. Li W; Zhang X; Xi X; Li Y; Quan H; Liu S; Wu L; Wu P; Lan W; Shao Y; Li H; Chen K; Hu Z Cancer Med; 2020 Jun; 9(12):4371-4385. PubMed ID: 32349184 [TBL] [Abstract][Full Text] [Related]
22. MiR-455-3p downregulation facilitates cell proliferation and invasion and predicts poor prognosis of osteosarcoma. Yi X; Wang Y; Xu S J Orthop Surg Res; 2020 Oct; 15(1):454. PubMed ID: 33008443 [TBL] [Abstract][Full Text] [Related]
23. GDF15 promotes osteosarcoma cell migration and invasion by regulating the TGF‑β signaling pathway. Chen G; Wang M; Liu X Mol Med Rep; 2019 Nov; 20(5):4262-4270. PubMed ID: 31545486 [TBL] [Abstract][Full Text] [Related]
24. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma. Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858 [TBL] [Abstract][Full Text] [Related]
25. Identification of abnormally high expression of POGZ as a new biomarker associated with a poor prognosis in osteosarcoma. Zheng S; Liu Y; Sun H; Jia J; Wu T; Ding R; Cheng X Eur J Histochem; 2021 Sep; 65(3):. PubMed ID: 34474553 [TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p. Yang C; Wu K; Wang S; Wei G J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226 [TBL] [Abstract][Full Text] [Related]
27. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer. Liu R; Hu Y; Liu T; Wang Y BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma. Yang J; Cheng D; Zhou S; Zhu B; Hu T; Yang Q Int J Mol Sci; 2015 Dec; 16(12):28635-46. PubMed ID: 26633383 [TBL] [Abstract][Full Text] [Related]
29. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142. Zhang L; Zhao G; Ji S; Yuan Q; Zhou H Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139 [TBL] [Abstract][Full Text] [Related]
30. Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes. Qi W; Yan Q; Lv M; Song D; Wang X; Tian K Pathol Oncol Res; 2021; 27():1609782. PubMed ID: 34335109 [No Abstract] [Full Text] [Related]
31. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma. Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383 [TBL] [Abstract][Full Text] [Related]
32. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis. Zhu B; Cheng D; Li S; Zhou S; Yang Q Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247 [TBL] [Abstract][Full Text] [Related]
33. MTHFD1L as a folate cycle enzyme correlates with prognostic outcome and its knockdown impairs cell invasive behaviors in osteosarcoma via mediating the AKT/mTOR pathway. Wang L; Yang Y; Wang XM; Wang CQ; Zhang YM; Li BL J Recept Signal Transduct Res; 2020 Dec; 40(6):584-590. PubMed ID: 32456526 [TBL] [Abstract][Full Text] [Related]
34. lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1α in osteosarcoma. Tan H; Zhao L J Cell Biochem; 2019 Apr; 120(4):6502-6514. PubMed ID: 30485482 [TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis to identify PUS7 as a prognostic biomarker from pan-cancer analysis to osteosarcoma validation. Dong B; Wang B; Fan M; Zhang J; Zhao Z Aging (Albany NY); 2024 May; 16(10):9188-9203. PubMed ID: 38819212 [TBL] [Abstract][Full Text] [Related]
36. PDE1B, a potential biomarker associated with tumor microenvironment and clinical prognostic significance in osteosarcoma. Chen Q; Xing C; Zhang Q; Du Z; Kong J; Qian Z Sci Rep; 2024 Jun; 14(1):13790. PubMed ID: 38877061 [TBL] [Abstract][Full Text] [Related]
37. LncRNA DSCAM-AS1 promoted cell proliferation and invasion in osteosarcoma by sponging miR-101. Yu CL; Xu NW; Jiang W; Zhang H; Ma Y Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7709-7717. PubMed ID: 32744697 [TBL] [Abstract][Full Text] [Related]
38. Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients. Li LQ; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Khader MA; Jia-Wen ; Tao-Liu ; Li JZ Aging (Albany NY); 2020 Nov; 12(22):22906-22926. PubMed ID: 33203792 [TBL] [Abstract][Full Text] [Related]
39. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity. Zucchini C; Manara MC; Cristalli C; Carrabotta M; Greco S; Pinca RS; Ferrari C; Landuzzi L; Pasello M; Lollini PL; Gambarotti M; Donati DM; Scotlandi K J Exp Clin Cancer Res; 2019 Dec; 38(1):503. PubMed ID: 31878963 [TBL] [Abstract][Full Text] [Related]
40. MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets. Lopes LJS; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia-Filho RJ; Toledo SRC Mol Carcinog; 2017 Jun; 56(6):1630-1641. PubMed ID: 28112450 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]